Attention-deficit/hyperactivity disorder (ADHD) symptoms, craving to smoke, and tobacco withdrawal symptoms in adult smokers with ADHD

Drug and Alcohol Dependence

Volumn 124, Issue 3, 2012, Pages 268-273

  Berlin, Ivan ^a   Hu, Mei Chen ^b   Covey, Lirio S ^c   Winhusen, Theresa ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

ADHD symptoms; Craving to smoke; Nicotine withdrawal symptoms; Smoking cessation

Indexed keywords

METHYLPHENIDATE; NICOTINE PATCH; PLACEBO;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSMOTIC RELEASE ORAL SYSTEM; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SYMPTOM; TOBACCO DEPENDENCE; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ADDICTIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE CESSATION PRODUCTS;

NICOTIANA TABACUM;

EID: 84863994589     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.01.019     Document Type: Article

References (31)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC. rev. 4th edition.
2. Adler L., Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivitydisorder. Psychiatr. Clin. N. Am. 2004, 27:187-201.
3. Berlin I., Jacob N., Coudert M., Perriot J., Schultz L., Rodon N. Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS trial. A randomized study in smokers with medical comorbidities. Addiction 2011, 106:833-843.
4. Conners C.K., Levin E.D., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., Rose J.E., March J. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol. Bull. 1996, 32:67-73.
5. Covey L.S., Manubay J., Jiang H., Nortick M., Palumbo D. Smoking cessation and inattention or hyperactivity/impulsivity: a post hoc analysis. Nicotine Tob. Res. 2008, 10:1717-1725.
6. Covey L.S., Hu M.C., Winhusen T., Weissman J., Berlin I., Nunes E.V. OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: racial/ethnic differences. Drug Alcohol Depend. 2010, 110:156-159.
7. Covey L.S., Hu M.C., Green C.A., Brigham G., Hurt R.D., Adler L., Winhusen T. An exploration of site effects in a multisite trial of OROR-methylphenidate for smokers with attention deficit/hyperactivity disorder. Am. J. Drug Alcohol Abuse 2011, 37:392-399.
8. Dawkins L., Powell J.H., Pickering A., Powell J., West R. Patterns of change in withdrawal symptoms, desire to smoke, reward motivation and response inhibition across 3 months of smoking abstinence. Addiction 2009, 104:850-858.
9. Diggle P.J., Liang K.Y., Zeger S.L. Analysis of Longitudinal Data 2004, Oxford University Press, Oxford, UK.
10. DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation 1998, Guilford Press, New York.
11. Gehricke J.G., Hong N., Wigal T.L., Chan V., Doan A. ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD. Pharmacol. Biochem. Behav. 2011, 98:485-491.
12. Gehricke J.G., Hong N., Whalen C.K., Steinhoff K., Wigal T.L. Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder. Psychol. Addict. Behav. 2009, 23:644-655.
13. Gray K.M., Baker N.L., Carpenter M.J., Lewis A.L., Upadhyaya H.P. Attention-deficit/hyperactivity disorder (ADHD) confounds nicotine withdrawal self-report in adolescent smokers. Am. J. Addict. 2010, 19:325-331.
14. Gray K.M., Upadhyaya H.P. Tobacco smoking in individuals with attention-deficit/hyperactivity disorder: epidemiology and pharmacological approaches to cessation. CNS Drugs 2009, 1:661-668.
15. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry 1986, 43:289-294.
16. Humfleet G.L., Prochaska J.J., Mengis M., Cullen J., Muñoz R., Reus V., Hall S.M. Preliminary evidence of the association between the history of childhood attention-deficit/hyperactivity disorder ad smoking treatment failure. Nicotine Tob. Res. 2005, 7:453-460.
17. Kollins S.C., McClernon J., Fuemmeler B.F. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch. Gen. Psychiatry 2005, 62:1142-1147.
18. Lambert N.M., Hartsough C.S. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J. Learn. Disabil. 2000, 33:314-316.
19. Levin E.D., Conners C.K., Sparrow E. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl.) 1996, 123:55-63.
20. Little R., Rubin D. Statistical Analysis with Missing Data 1987, Wiley, New York.
21. McBurnett K., Starr H.L. OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder. Expert Opin. Pharmacother. 2011, 12:315-324.
22. McClernon F.J., Van Voorhees E.E., English J., Hallyburton M., Holdaway A., Kollins S.H. Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial. Nicotine Tob. Res. 2011, 13:784-792.
23. McClernon F.J., Kollins S.H., Lutz A.M., Fitzgerald D.P., Murray D.W., Redman C., Rose J.E. Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study. Psychopharmacol. (Berl.) 2008, 197:95-105.
24. Pomerleau O.F., Downey K.K., Stelson F.W., Pomerleau C.S. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J. Subst. Abuse 1995, 7:373-378.
25. Poltavski D.V., Petros T. Effects of transdermal nicotine on attention in adult nonsmokers with and without attention deficits. Physiol. Behav. 2006, 87:614-624.
26. Potter A.S., Newhouse P.A. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit hyperactivity disorder. Psychopharmacology 2004, 176:182-194.
27. Rush C.R., Higgins S.T., Vansickel A.R., Stoops W.W., Lile J.A., Glaser P.E. Methylphenidate increases cigarette smoking. Psychopharmacology 2005, 181:781-789.
28. Tercyak K.P., Lerman C., Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. J. Am. Acad. Child Adolesc. Psychiatry 2002, 41:799-805.
29. Vansickel A.R., Stoops W.W., Glaser P.E.A., Rush C.R. A pharmacological analysis of stimulant-induced increases in smoking. Psychopharmacology 2007, 193:305-313.
30. Volkow N.D., Wang G.J., Newcorn J., Telang F., Solanto M.V., Fowler J.S., Logan J., Ma Y., Schulz K., Pradhan K., Wong C., Swanson J.M. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-eficit/hyperactivity disorder. Arch. Gen. Psychiatry 2007, 64:932-940.
31. Winhusen T.M., Somoza E.C., Brigham G.S., Liu D.S., Green C.A., Covey L.S., Croghan I.T., Adler L.A., Weiss R.D., Leimberger J.D., Lewis D.F., Dorer E.M. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J. Clin. Psychiatry 2010, 71:1680-1688.